Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
What Could be Nicer than NICE?
1 August 2004
The National Institute for Clinical Excellence is the closest anyone has yet come to fulfilling the economist’s dream of how priority-setting in health care should be…
Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Developments
1 November 2003
The purpose of this book is to bring together a collection of papers by acknowledged experts in the field of trial-based health economic evaluation to provide…
From Efficacy to Cost-Effectiveness
1 May 1998
This OHE Briefing summarises the presentations and discussion at the session on ‘Efficacy to cost-effectiveness’ at the Conference of the International Society for Technology Assessment in…
Trends in Economic Evaluation
1 April 1998
The aim of this paper is to consider recent trends in the volume and characteristics of economic evaluation literature by interrogating the Health Economic Evaluations Database…
The Pros and Cons of Modelling in Economic Evaluation
1 May 1997
The participants were: Professor Bernard Bloom. University of Pennsylvania, USA Professor Martin Buxton. Director of the Health Economics Research Group, University of Brunel, UK Professor Michael…
Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
1 October 1996
The use of models in economic studies evaluating medicines and other health technologies has become a controversial issue. This is because study results now matter –…
Handling Uncertainty in the Results of Economic Evaluation
1 September 1995
The recent increase in the number of published economic evaluations has been considerable [Wellcome, 1992; Udvarhelyi et al, 1992]. It is of some concern, however that…
Cost-Benefit Analysis of Medicines – a Guide for Industry
1 January 1989
The objectives of this booklet are twofold. First, to describe in simple terms the state of the art in undertaking economic studies to demonstrate the benefits…